Excipients vary by manufacturer (e.g., lactose monohydrate, magnesium stearate, cellulose).

Available in strengths such as 25 mg, 50 mg, 100 mg, and 200 mg tablets. May come as immediate-release or dispersible (chewable) tablets depending on brand.

– Usually taken once or twice daily, with or without food.

– Doses are gradually increased to reduce the risk of rash.

– Do not stop suddenly without medical advice — abrupt discontinuation may trigger seizures or mood relapse.

– Blurred or double vision.

– Nausea or vomiting.

– Tremor or difficulty sleeping.

– Rare but serious: severe skin reactions (Stevens-Johnson syndrome), rash, fever, swollen lymph nodes, or liver problems. Immediate medical attention required if rash or allergic reaction occurs.

Safety Advice

Do not stop abruptly — risk of withdrawal seizures or mood changes.

– Monitor for rash during early treatment (can be life-threatening if severe).

– Inform your doctor if you are taking valproate, carbamazepine, or other antiepileptic drugs — dosage adjustments may be needed.

– Avoid alcohol and operating machinery until you know how it affects you.

– Use in pregnancy or breastfeeding only if prescribed; may affect fetal development.

– Regular monitoring may be required for liver function and blood counts.

– Lamitor 100 mg (Intas Pharmaceuticals)

– Lametec 100 mg (Cipla)

– Lamoz 100 mg (Sun Pharma)

(All contain Lamotrigine as the active ingredient.)

Origin depends on the brand. Lamotrigine was originally developed by GlaxoSmithKline (UK), but now manufactured by several companies worldwide (UK, India, USA, etc.).